Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nima Almassi

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Urology|March 25, 2023
Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSATarik Benidir, Zaeem Lone, Andrew Wood, et al.
Clinical Genitourinary Cancer|December 25, 2025
Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing TherapyMonica S Nair, Jessica Scarborough, Chandana A Reddy, et al.
Urologic Oncology|October 5, 2025
IsoPSA density improves risk stratification and biopsy decision-making for clinically significant prostate cancerBetty Wang, Tarik Benidir, Kristina Dortche, et al.
Urology Practice|January 8, 2026
Histologic Patterns and Germline Genetic Testing Outcomes in Presumed Sporadic Bilateral Renal MassesKieran Lewis, Jason M Scovell, Eran N Maina, et al.
Minerva Urology and Nephrology|September 2, 2025
Parenchymal volume and functional recovery after clamped partial nephrectomy: potential discrepanciesKieran Lewis, Akira Kazama, Carlos Munoz Lopez, et al.
BJU International|December 10, 2024
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal functionEiftu S Haile, Zaeem Lone, David Shin, et al.
BJUI Compass|March 2, 2026
Preoperative predictors of adverse pathology and recurrence-free survival for patients with renal massesAkira Kazama, Carlos Munoz-Lopez, Worapat Attawettayanon, et al.
The Journal of Clinical Investigation|June 26, 2018
HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancerMohammad Alyamani, Hamid Emamekhoo, Sunho Park, et al.
Urologic Oncology|May 10, 2024
Parenchymal obliteration by renal masses: Functional and oncologic implicationsAkira Kazama, Carlos Munoz-Lopez, Worapat Attawettayanon, et al.
Urology|June 20, 2017
Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active SurveillanceVishnu Ganesan, Charles Dai, Yaw A Nyame, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Urology|March 25, 2023
Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSATarik Benidir, Zaeem Lone, Andrew Wood, et al.
Clinical Genitourinary Cancer|December 25, 2025
Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing TherapyMonica S Nair, Jessica Scarborough, Chandana A Reddy, et al.
Urologic Oncology|October 5, 2025
IsoPSA density improves risk stratification and biopsy decision-making for clinically significant prostate cancerBetty Wang, Tarik Benidir, Kristina Dortche, et al.
Urology Practice|January 8, 2026
Histologic Patterns and Germline Genetic Testing Outcomes in Presumed Sporadic Bilateral Renal MassesKieran Lewis, Jason M Scovell, Eran N Maina, et al.
Minerva Urology and Nephrology|September 2, 2025
Parenchymal volume and functional recovery after clamped partial nephrectomy: potential discrepanciesKieran Lewis, Akira Kazama, Carlos Munoz Lopez, et al.
BJU International|December 10, 2024
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal functionEiftu S Haile, Zaeem Lone, David Shin, et al.
BJUI Compass|March 2, 2026
Preoperative predictors of adverse pathology and recurrence-free survival for patients with renal massesAkira Kazama, Carlos Munoz-Lopez, Worapat Attawettayanon, et al.
The Journal of Clinical Investigation|June 26, 2018
HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancerMohammad Alyamani, Hamid Emamekhoo, Sunho Park, et al.
Urologic Oncology|May 10, 2024
Parenchymal obliteration by renal masses: Functional and oncologic implicationsAkira Kazama, Carlos Munoz-Lopez, Worapat Attawettayanon, et al.
Urology|June 20, 2017
Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active SurveillanceVishnu Ganesan, Charles Dai, Yaw A Nyame, et al.
Pageof 9